Quantification of glomerular TGF-1 mRNA in patients with diabetes mellitus. Transforming growth factor-fll (TGF-131) is a primary determinant of the mesangial expansion observed in diabetic nephropathy. In this study, we quantitated the levels of intraglomerular TCF-J31 mRNA in patients with diabetes mellitus using a competitive polymcrase chain reaction (PCR) method. Renal biopsy specimens were obtained from 29 patients with non-insulin-dependent diabetes mellitus. Total RNA was extracted from the glomeruli and reverse transcribed into eDNA with reverse transcriptase. To prepare samples containing identical amounts of f3-actin eDNA (8 pg), we performed competitive PCR by co-amplifying mutant templates of -actin with a unique EcoRI site. We also used this competitive PCR method to measure TGF-J31 eDNA by co-amplifying mutant templates of TGF-pl. We observed higher expression of TGF-f31 mRNA in glomeruli of patients with diabetic nephropathy as compared with normal glomeruli. Intraglomerular TGF-/31 mRNA was elevated, even in the early stage of diabetic nephropathy. Moreover, levels of intraglomerular TGF-f31 mRNA correlated with values of HhAlc. These data suggest that hyperglycemia induces intraglomerular TGF-f31 mRNA expression in vivo, and that TGF-1 overproduction may be associated with the progression of diabetic nephropathy.
expression in vivo, and that TGF-1 overproduction may be associated with the progression of diabetic nephropathy.
Diabetic nephropathy is a fatal complication of diabetes mdlitus and a common cause of end-stage renal disease [1] . It is characterized histologically by expansion of the glomerular mesangium due to art increase in extracellular matrix (ECM) proteins [2] . Although hyperglycemia plays a key role in the initiation and progression of diabetic nephropathy, the mechanisms by which hyperglycemia causes the histologic change remain to be elucidated. There have been several reports indicating that various cytokines and vasoactive peptides were associated with the pathogenesis of diabetic nephropathy. Atrial natriuretic peptide increased glomerular filtration rate [3] . Overproduction of platelet-derived growth factor B (PDGF-B), tumor necrosis factor-a (TNF-a), and basic fibroblast growth factor (bFGF), all of which are mitogenic for cultured mesangial cells, has been observed in diabetic rats [4] .
Transforming growth factor-f31 (TGF-pl) may be a primary determinant of mesangial expansion observed in diabetic nephropathy for the following reasons. Firstly, Yamamoto et al have demonstrated enhanced expression of TGF-f31 in the glomeruli of diabetic rats and localization of the TGF-pl protein in patients with diabetic nephropathy by immunohistochemistry [5] . Sec- al have shown that rat mesangial hypertrophy is induced when exposed to TGF-J31 in vitro [7] .
Quantitative analysis of the glomerular mRNA encoding TGF-f31 in cases of human diabetic nephropathy is difficult since few renal biopsy specimens are available. Peten et al have shown that human glomerular mRNA encoding for a2 (IV) collagen can be measured by a competitive polymerase chain reaction (PCR) method [81. Our previous study have also demonstrated that levels of glomerular TGF-pl mRNA can be measured accurately by a competitive PCR method [9] . In this study, we quantitated glomerular expression of TGF-f31 mRNA in patients with diabetic nephropathy to determine whether TGF-/31 plays a role in the progression of diabetic nephropathy. Furthermore, we investigated the correlation between the levels of intraglomerular TGF-/31 mRNA and several clinical parameters.
Methods

Patients
Renal biopsy specimens were obtained from 29 patients with non-insulin-dependent diabetes mellitus (NIDDM). All patients gave their informed consent. Table I summarizes the clinical characters of these patients.
We obtained control specimens from ii patients (8 males and 3 females) with renal cell cancer. The mean age of the patients with renal cell cancer was 58 10 years (mean SD). The mean values of creatinine clearance were 91 22 mI/mm (mean SD). The control specimens, which consisted of the remaining normal kidney after resections for renal cell cancer, showed only minor changes in glomeruli by light microscopy (normal glomeruli). cut into 3 tm sections. The sections were stained with the periodic acid-Schiff reagent. Patients were divided into three groups (Diffuse I to Diffuse III) based on the extent of mesangial expansion Table 1 . Characteristics of patients according to the Geilman's classification (Fig. 1 ) [10] , with the exception that the Diffuse III group in this study contained both the Diffuse III and Diffuse IV groups defined by the Geilman's classification.
Immunohistochemical localization of type IV collagen
Paraffin sections (4 pm) were deparaffinized and endogenous peroxidase activity was denatured with 1% hydrogen peroxide. After incubation for five minutes at 37°C in 0.4 mg/mi proteinase K (Dako Japan Co., Kyoto, Japan), the sections were irradiated with microwaves for two minutes. Sections were subsequently incubated with 10% normal goat serum, then reacted with a polyclonal antibody to human type IV collagen (Chemicon International Inc., Temeula, CA, USA) for two hours at 37°C. After washing with phosphate-buffered saline (PBS), the sections processed further using LSAB kits (Dako). The staining intensity of collagen type IV was graded semiquantitatively as weak (Grade I), moderate (Grade II), and strong (Grade III).
Immunohistochemical localization of TGF-f31 Frozen sections (3 m) were fixed in cold aceton for 10 minutes before staining. After washing with PBS, sections were reacted with a polyclonal antibody to human TGF-/31 (King Brewing Co., Kakogawa, Japan) for two hours at 37°C. After washing with PBS, the sections were incubated with fluorescein-conjugated F(ah')2 goat anti-rabbit IgG (Cappel, Malvern, PA, USA), which had been absorbed with normal human plasma before use. For nuclear staining, propydium iodide (Sigma, St. Louis, MO, USA) was used. The section thus prepared was examined with a laser confocal microscope (MRC-600, Bio-Rad, Tokyo, Japan).
Total RNA extraction and reverse transcription Glomeruli were obtained by dissecting 10 to 20% of each of the renal biopsy specimens under phase-contrast microscopy as described previously [11] . We extracted total RNA from glomeruli as described previously [91. Total RNA was reverse transcribed into eDNA with I unit/ps of RAV-2 reverse transcriptase (Amersham, Aylesbury, UK). The reaction mixture also contained 100 p of random hexamers, 1 m of dATP, dCTP, dTTP, and dGTP, and 1 U/1id RNase inhibitor (Amersham). The reaction mixtures was incubated at 42°C for one hour, then heated to 95°C for five minutes to denature the RNA-cDNA hybrid and to inactivate the reverse transcriptase.
Oligonucleotide primers
The primers were synthesized on a PCR-Mate DNA synthesizer (Applied Biosystems, Inc., Foster, CA, USA Mild enlargement of the mesangial area is observed in a diffuse pattern (Diffuse II) (upper right, periodic acid-Schiff staining, x 400). The mesangial area is increased and the capillary wall is diffusely thickened. Some capillary lumina are reduced in size due to the mesangial enlargement (Diffuse III) (bottom left, periodic acid-Schiff staining, >< 400). Mesangial expansion is marked. In Diffuse IV, nodules are occasionally observed (bottom right, periodic acid-Schiff staining, x 400).
cDNA was amplified with the following primers: AGCGACTC-GCCAGAGTGGTTATCTT (bases 1411-1435) as the sense primer and TFATGCTGGTTGTACAGGGCCAGGA (bases 1860-1884) as the antisense primer [13] . These primers were derived from separate exons to inhibit amplification of any contaminating genomic DNA sequences.
Generation of competitive mutant templates
To circumvent the problem of variability in amplification efficiency, competitive templates were generated by site specific mutagenesis using two mutant primers as described by Higuchi, Krummel and Saiki [141. Mutant primers 30 base pairs in length contained a single base pair change which created a unique EcoRI site in the competitive templates of the human f3-actin gene and the human TGF-131 gene. Mutant fragments were subcloned into pUC 18 and verified by sequencing [9] .
Competitive PCR
Competitive PCR was performed as described by Gilliland, Perrin and Bunn [15] . A master mix containing primers, PCR buffer, Taq polymerase (Perkin Elmer/Cetus, Norwalk, CT, USA) and an appropriate amount of eDNA was prepared. Ten microliters of the competitive template at various concentrations were The amount of glomerular /3-actin eDNA was determined by densitometric analysis of ethidium bromide staining intensity.
Southern blot hybridization
Southern blot analysis was used to determine the amount of glomerular TGF-/31 eDNA. DNA underwent electrophoresis, denaturation and transfer to a Hybond-N+ filter (Amersham).
After drying at 80°C for two hours, the filters were prehybridized in 6 X SSC, 10 x Denhardt's solution, 1% SDS and 50 sg/ml salmon sperm DNA at 42°C for three hours. They were then hybridized with a oligonucleotide probe (GGTAGTGAACCCG-TTGATGTCCACTTGCA) that had been 5' end labeled with [y-32P] ATP. This probe was complementary to sequence of exon 4 and 5 of the TGF-131 gene. The filters were hybridized at 37°C overnight, washed with 6 X SSC and 0.1% SDS at room temperature three times for 10 minutes and at 60°C for 30 minutes. After exposure to Kodak X-Omat film (Eastman Kodak Co., Rochester, NY, USA), the amount of cDNA was analyzed by densitometry.
We performed competitive PCR on 10 samples on five different days and found interassay variation that was consistently below 15%.
Statistical analysis
To compare means among more than two groups, but the underlying distribution was not assumed to hold normal, a multiple comparison test for a nonparametric, the Kruskal-Wallis test was used. When the average ranks of the groups were judged unequal by the test, the Dunn procedure was followed for a comparison of specific groups. All data were expressed as the median (25th percentile, 75th percentile). Correlations were assessed by linear regression analysis. P value < 0.05 was considered to be statistically significant.
Results
Quantitative analysis of intraglomerular TGF-/31 in patients with diabetes mellitus
The initial competitive PCR allowed us to determine the amount of intraglomerular /3-actin eDNA. We found that the levels of intraglomerular /3-actin eDNA were significantly higher in the patients with diabetic nephropathy [13.4 (7.7, 16) pg/ glomerulus] than in the normal glomeruli [7.2 (4.2, 11.5) pg/ glomerulus; P < 0.0011. Therefore, we should adjust the samples to equal concentrations of J3-actin cDNA. We used samples containing 8 pg of 13-actin eDNA to determine the amount of intraglomerular TGF-f31 mRNA. We again performed competitive PCR by co-amplifying the mutant templates of TGF-/31. Figure 2 shows the representative result of competitive PCR in normal glomeruli and glomeruli obtained from patients with diabetes mellitus. Raising amounts of the mutant TGF-/31 cDNA increasingly inhibited amplification of authentic TGF-131 eDNA. The ratio of mutant to authentic band density was calculated.
Levels of intraglomerular TGF-/31 mRNA were significantly elevated in patients with diabetes mellitus as compared with levels in normal glomeruli [0.75 (0.4, 1.33) fg/pg 13-actin vs. 0.2 (0.13, 0.36) fg/pg /3-actin, P < 0.001]. Patients were divided into three groups according to their excretion of urinary albumin: 13 patients with normoalbuminuria, 7 patients with microalbuminuria (> 15 .Lg/min), and 9 patients with overt albuminuria (> 200 gImin) [16] . The amounts of intraglomerular TGF-/31 mRNA in patients with normoalbuminuria, microalbuminuria and overt albuminuria were 0.50 (0.40, 1.00), 1.00 (1.00, 1.88), 0.73 (0.39, 1.39) fglpg 13-actin, respectively. TGF-/31 mRNA levels were significantly elevated in patients from all groups compared to normal glomeruli (Fig. 3 ). Patients were also divided into three groups based on the extent of mesangial expansion seen on renal biopsy (Diffuse I to Diffuse III). The amounts of intraglomerular TGF-J31 mRNA patients from all groups compared to normal glomeruli (Fig. 4) . These results indicate that high levels of glomerular TGF-/31 mRNA can be observed even in the early stage of diabetic nephropathy.
Correlation between glomerular TGF-f31 mRNA and staining intensity of collagen type IV To examine the correlationship between the levels of intraglomerular TGF-/31 mRNA and collagen type IV synthesis, we performed immunostaining with anti-collagen type IV in 27 patients with diabetic nephropathy. Positive immunostaining for collagen type IV was observed in the mesangium, glomerular basement membrane, and Bowman's capsule (Fig. 5) . The levels of intraglomerular TGF-131 mRNA were positively correlated with the staining intensity of collagen type IV (Fig. 6 ).
Immunohistochemical localization of TGF-J31 in diabetic nephropathy To elucidate the production of TGF-f31 protein in glomeruli, we performed immunostaining with anti-TGF-/31. Frozen sections were obtained from 7 patients with diabetes mellitus (patient number 3, 4, 7, 17, 21, 24, 28 in Table 1 ). Control specimens were obtained from five patients with renal cell cancer. Positive staining were observed in the mesangial area as shown in Figure 7 . All of the glomeruli from the seven patients with diabetes mellitus were strongly positive for TGF-/31, whereas glomeruli from the control specimens showed only trace staining. The staining were negative when the primary antibody was preabsorbed with purified TGF-p1 or when the tissues were incubated with the secondary a competitive PCR method. Previous studies have shown that TGF-f31 protein and mRNA are mainly observed in mesangial area [5, 17, 18] , Thercfore, TGF-p1 is thought to be mainly produced by mesangial cells in glomeruli. TGF-pl functions in tissue repair by stimulating the synthesis of extracellular matrix and also inhibiting its degradation [19, 20] . [22, 23] . Several studies have shown 3.0 3, 5 that TGF-1 is closely associated with mesangial matrix increase in diabetic rat, mouse and human glomeruli [5] [6] [7] . These previous reports suggest that TGF-j31 may be a main determinant of mesangial expansion observed in diabetic nephropathy. However, the prior data in cell culture, animal experiments and human tissue analysis have all focused on insulin-dependent diabetes mellitus (IDDM). We have speculated the same association between TGF-f31 and diabetic nephropathy due to NIDDM. We found that significantly higher levels of intraglomerular TGF-f31 mRNA were observed in patients with NIDDM and intraglomerular TGF-f31 mRNA levels were elevated even in the early stage of diabetic nephropathy. In addition, TGF-f31 protein was localized in the glomeruli of patients with NIDDM, Accordingly, it is conceivable that overproduction of TGF-131 in glomeruli is associated with the initiation and progression of diabetic nephropathy due to NIDDM as well as IDDM. TOF-pi is secreted as a biologically latent form. Therefore, TOP-/fl mRNA levels may not parallel TGF-/31 activity. In this study, intraglomerular levels of TGF-/31 mRNA were correlated with the amounts of glomerular collagen type IV. As mature TGF-/31, which is functionally active, induces collagen type IV synthesis in cultured mesangial cells [26, 31] Quantifying the expression of mRNA can provide important information about protein levels and thus biological activity. We used competitive PCR to measure the expression of intraglomerular TGF-/31 mRNA in patients with diabetic nephropathy. This procedure uses a competitive mutant template of the same sequence as the target except for the addition of a restriction site by a single base substitution. Accordingly, differences in amplification efficiency should be negligible. However, there are two other significant problems in quantitating the intraglomerular expression of mRNA; a difficulty in quantitating the amount of total RNA and an inconsistency in the efficiency of reverse transcription. To circumvent these probrems, we first quantified the amounts of mRNA expression of the "housekeeping" gene, /3-actin, and then diluted the samples so they contained equal amounts of /3-actin eDNA.
Levels of glomerular TOP-/fl mRNA can be measured accurately by a competitive PCR method. However, we cannot identify which cells in glomeruli are responsible for TOF-/31 production by Discussion hypertrophy and normalization of blood glucose levels with insulin treatment attenuates the increase in TGF-/31 expression in diabetic rats [32] . Strict glycemic control has been shown to ameliorate the progression of human diabetic nephropathy [33] .
The present study indicated that values for intraglomerular TGF-/31 mRNA correlated well with HbAlc values. These data suggest that glycemic control slow the progression of diabetic nephropathy partly via the inhibition of TGF-/31 production in glomeruli. To clarify the association between glycemic control and the inhibition of TGF-f31 production, we should perform the follow-up study and measure the intraglomerular TGF-pl mRNA after strict glycemic control.
